Literature DB >> 1413048

Diltiazem co-administration reduces cyclosporine toxicity after heart transplantation: a prospective randomised study.

P Macdonald1, A Keogh, J Connell, A Harvison, D Richens, P Spratt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1413048

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.

Authors:  Yong Song; Wujun Xue; Puxun Tian; Xiaoming Ding; Xiaoming Pan; Hang Yan; Jun Hou; Xinshun Feng; Heli Xiang; Xiaohui Tian; Gaoping Qin; Xiaohu Fan
Journal:  Eur J Clin Pharmacol       Date:  2011-01-29       Impact factor: 2.953

Review 2.  The clinical and economic potential of cyclosporin drug interactions.

Authors:  J E Martin; A J Daoud; T J Schroeder; M R First
Journal:  Pharmacoeconomics       Date:  1999-04       Impact factor: 4.981

Review 3.  Drug interactions with cisapride: clinical implications.

Authors:  E L Michalets; C R Williams
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

4.  [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].

Authors:  H Sperschneider; C Wagner; A Korn; U Christians
Journal:  Med Klin (Munich)       Date:  1997-10-15

5.  The effects of diltiazem in renal transplantation patients treated with cyclosporine A.

Authors:  Wujun Xue; Yong Song; Puxun Tian; Xiaoming Ding; Xiaoming Pan; Hang Yan; Jun Hou; Xinshun Feng; Heli Xiang; Xiaohui Tian
Journal:  J Biomed Res       Date:  2010-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.